Institut de Pharmacologie de Sherbrooke (IPS)

Therapeutic Approaches: Biologics, Small Molecules, peptides, macrocycles

Therapeutic Areas of Expertise: Cardiology, Infectious Diseases, Oncology, Pain

Center/Program Highlights:Institut de Pharmacologie de Sherbrooke focuses on the discovery of new drugs and new diagnostic agents , as well as the validation of emerging drug targets and new technologies to support drug discovery. Major areas of focus include cardiovascular diseases, pain, brain and prostate cancer, and infectious diseases. A particular area of expertise is GPCRs, proteases, transcription factors, peptidic and macrocyclic chemistry as well as various imaging modalities.

Sources of Funding: Federal/State, Industry Partnerships, University


Institutional Affiliation(s): Université de Sherbrooke

Institut de pharmacologie de Sherbrooke
3001, 12e av nord
Québec, J1H 5N4

Center/Program Start Date: 1998

Number of Employees: 250